Meriwether Wealth & Planning’s United Therapeutics UTHR Stock Holding History

Meriwether Wealth & Planning’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17.9K	Buy	+33	New	+$17.1K	0.01%	354

Other funds holding UTHR

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Meriwether Wealth & Planning's UTHR Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in United Therapeutics (UTHR) in Q3 2026: 33 shares worth $17.9K. The stake represents 0.01% of the portfolio and ranks #354 among its holdings.

240 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

Meriwether Wealth & Planning held 33 shares of United Therapeutics worth $17.9K as of Q3 2026.
United Therapeutics was a new Meriwether Wealth & Planning position in Q3 2026.
United Therapeutics made up 0.01% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #354 holding.
240 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.